119 related articles for article (PubMed ID: 16638193)
1. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
Gao WR; Hou J; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
[TBL] [Abstract][Full Text] [Related]
2. Preliminary investigation of 2-methoxyestradiol inducing differentiation of myeloma cell line CZ-1.
Hou J; Xiong H; Gao WR; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):65-9. PubMed ID: 16584594
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 2-methoxyestradiol on cell differentiation of myeloma cell line CZ-1].
Gao WR; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):197-9. PubMed ID: 15949258
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
Gao WR; Hou J; Xiong H
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
[TBL] [Abstract][Full Text] [Related]
5. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
6. [Effect of 2-methoxyestradiol on proliferation and apoptosis of myeloma cell lines].
Gao WR; Hou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):293-7. PubMed ID: 15854295
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of c-myc expression by Blimp-1 during the differentiation of myeloma cells].
Zhou X; Zhou F; Jiang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):318-22. PubMed ID: 17877160
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells.
Hou J; Xiong H; Gao W; Jiang H
Leuk Res; 2005 Sep; 29(9):1059-67. PubMed ID: 16038732
[TBL] [Abstract][Full Text] [Related]
9. [Significance of CD138/syndecan-1 for multiple myeloma immunophenotypes].
Zhuang JL; Wang X; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1023-7. PubMed ID: 16403272
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
[TBL] [Abstract][Full Text] [Related]
12. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
Chauhan D; Catley L; Hideshima T; Li G; Leblanc R; Gupta D; Sattler M; Richardson P; Schlossman RL; Podar K; Weller E; Munshi N; Anderson KC
Blood; 2002 Sep; 100(6):2187-94. PubMed ID: 12200384
[TBL] [Abstract][Full Text] [Related]
14. Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model.
Van Valckenborgh E; Matsui W; Agarwal P; Lub S; Dehui X; De Bruyne E; Menu E; Empsen C; van Grunsven L; Agarwal J; Wang Q; Jernberg-Wiklund H; Vanderkerken K
Leukemia; 2012 Jun; 26(6):1436-9. PubMed ID: 22289925
[No Abstract] [Full Text] [Related]
15. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid.
Huang H; Wu D; Fu J; Chen G
Leuk Lymphoma; 2009 Jun; 50(6):966-73. PubMed ID: 19373597
[TBL] [Abstract][Full Text] [Related]
18. Effect of levamisole on expression of CD138 and interleukin-6 in human multiple myeloma cell lines.
Nageshwari B; Merugu R
Indian J Cancer; 2017; 54(3):566-571. PubMed ID: 29798960
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
20. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Dingli D; Timm M; Russell SJ; Witzig TE; Rajkumar SV
Clin Cancer Res; 2002 Dec; 8(12):3948-54. PubMed ID: 12473611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
